Larvol Delta - Nxera-Pharma-to-Receive-US48-Million-in-Milestone-Payments-Following-Centessas-Initiation-of-Clinical-Development-of-ORX142-a-Novel-Orexin-Receptor-2-OX2R-Agonist

ORX142 - Centessa

https://www.globenewswire.com/news-release/2025/07/04/3110212/0/en/Nxera-Pharma-to-Receive-US-4-8-Million-in-Milestone-Payments-Following-Centessa-s-Initiation-of-Clinical-Development-of-ORX142-a-Novel-Orexin-Receptor-2-OX2R-Agonist.html

Jul 4, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next